Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09VSL
|
|||
Former ID |
DNC006881
|
|||
Drug Name |
1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea
|
|||
Synonyms |
CHEMBL216287; 1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea; SCHEMBL8925408; BDBM50191866
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H29N3O
|
|||
Canonical SMILES |
C1CNCCC1CNC(=O)NC23CC4CC(C2)CC(C4)C3
|
|||
InChI |
1S/C17H29N3O/c21-16(19-11-12-1-3-18-4-2-12)20-17-8-13-5-14(9-17)7-15(6-13)10-17/h12-15,18H,1-11H2,(H2,19,20,21)
|
|||
InChIKey |
ZQMNKAGVCNSSIW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.